Tuberculosis Infection Completed Phase 2 Trials for Rifapentine (DB01201)

Also known as: Tuberculosis (TB) / Tuberculosis / Tuberculous infections / TB / Tuberculosis NOS / Infection TBC / Infection tuberculosis / Tuberculosis (A15-A19)

IndicationStatusPhase
DBCOND0053683 (Tuberculosis Infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00814671Study of Daily Rifapentine for Pulmonary TuberculosisTreatment
NCT00023426TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of TuberculosisTreatment